Today: 28 June 2026
Browse Category

LSE:GSK.L 28 November 2025 - 2 March 2026

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

GSK shares rose 1.1% to 2,263 pence after the European Commission approved its twice-yearly asthma drug Exdensur and the company launched a new tranche of share buybacks. GSK will repurchase up to £0.45 billion in shares by April 24. The company also reported new real-world data showing its RSV vaccine Arexvy was 75.6% effective against RSV-related hospitalisation in adults over 60.
18 February 2026
··
GSK stock price in focus before London open after China starts Arexvy review

GSK stock price in focus before London open after China starts Arexvy review

China’s Center for Drug Evaluation has accepted GSK’s Arexvy RSV vaccine application for review, with a decision expected in 2027. GSK shares closed Tuesday up 0.42% at 2,168 pence ahead of the London open. JPMorgan raised its target price to £22.50, and the company’s next dividend goes ex-dividend on Feb. 19. Non-executive director Hal Barron sold 67,602 ADSs at $59.17 on Feb. 5.
11 February 2026
·
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares slipped 0.6% to 1,879.5p in London by 10:50 GMT as investors awaited detailed data from its phase III hepatitis B drug trial. Analysts pressed for cure rate and durability figures after GSK withheld specifics. A royalty dispute over cancer drug Jemperli is pending in U.S. court, with a trial set for July 2026. Investors are watching for updates at the Jan. 13 J.P. Morgan conference and Feb. 4 results.
9 January 2026
···
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
9 December 2025
···········
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The FTSE 100 closed near 9,660 on December 8, posting a total return of about 20–23% year-to-date, its best run since 2009. The Bank of England has held rates at 4% since August, with inflation at 3.6%. Markets expect a rate cut to 3.75% at the December 18 meeting. UK mortgage rates have dropped to their lowest since before September 2022.
8 December 2025
·········
GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK shares traded near 12-month highs on November 28, 2025, with London shares at 1,806p, up 0.2%, and New York ADRs at $48.02, just below their yearly peak. MarketBeat issued a fresh “Hold” consensus from seven analysts, with an average 12-month price target of $44.13, under current levels. The stock’s recent gains follow continued share buybacks and a busy drug pipeline.
28 November 2025
··

Stock Market Today

  • Netflix Shares Rally on Heavy Nasdaq Volume Ahead of Q2 Earnings
    June 28, 2026, 1:43 PM EDT. Netflix (NASDAQ:NFLX) shares surged 4.10% to $73.81 on heavy trading volume, with 300.6 million shares changing hands over five sessions, well above the 65-day average. The gain trimmed weekly losses but left the stock down 4.6%, still near its 52-week low of $70.86. Netflix is scheduled to report Q2 earnings on July 16, with analysts projecting earnings per share (EPS) of $0.79. The volume spike closely precedes earnings and follows news of an AI-driven ad partnership with Omnicom Media Group, boosting investor interest. Despite broader market declines including a 4.7% drop in the Nasdaq Composite, Wolfe Research maintained an outperform rating on Netflix with a $107 price target, citing priced-in growth concerns.

Latest articles

Energy stocks this week: U.S. sector ETF holds flat as oil falls

Energy stocks this week: U.S. sector ETF holds flat as oil falls

28 June 2026
Brent crude plunged 10.86% last week as Hormuz flows improved, but the Energy Select Sector SPDR Fund (XLE) fell just 0.4%, signaling investors are no longer trading energy stocks in lockstep with oil prices; this divergence matters now as refiners benefit from tight diesel margins while oilfield services face risks from a Norway lockout and rising U.S. rigs.
Micron (NASDAQ:MU) moves pull Nvidia (NASDAQ:NVDA), Apple (NASDAQ:AAPL) into focus this week for AI stocks

Micron (NASDAQ:MU) moves pull Nvidia (NASDAQ:NVDA), Apple (NASDAQ:AAPL) into focus this week for AI stocks

28 June 2026
Micron’s record $41.46 billion quarter and $50 billion Q4 outlook highlight surging memory demand as Apple hikes Mac and iPad prices after DRAM costs nearly double; with the Philadelphia semiconductor index down 7.9% last week, investors face a compressed four-day week to gauge if AI’s memory squeeze boosts profits or triggers a tech cost shock, as payrolls data and rate risks loom.
US stocks look to jobs data as traders shift from AI tech

US stocks look to jobs data as traders shift from AI tech

28 June 2026
Semiconductor stocks plunged 7.9% last week, their worst performance since April, dragging the S&P 500 down 2.05% as investors pulled nearly $20 billion from tech funds; strategists warn that continued weakness in mega-cap tech could weigh on cap-weighted indexes even as smaller stocks rally, with upcoming jobs data and rate expectations posing further risks.
Go toTop